New Delhi: The World Health Organisation (WHO) on Friday announced it has granted emergency approval to the COVID vaccine Covovax, Serum Institute of India’s version of the Novavax vaccine.
“Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2,” said Mariangela Simao, the WHO’s access to vaccines chief. “This listing aims to increase access particularly in lower-income countries,” NDTV reported.
Taking to Twitter, SII CEO Adar Poonawalla wrote: “This is yet another milestone in our fight against Covid-19, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration.”
On June 25, SII CEO Adar Poonawalla said Serum Insitutue began manufacturing the first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc.
Bhubaneswar: A few days after bombs were hurled at the residence of Food Supplies and…
Mumbai: Just days after its release on Christmas day, Varun Dhawan and Keerthy Suresh’s ‘Baby…
Mumbai: The year which we are about to bid goodbye to has seen many fresh…
Mumbai: Oppression and crime against women continue to haunt and hurt India. In an incident…
Bhubaneswar: In order to take the administration closer to the people, the Odisha government is…
Jaipur: Odisha made short work of Group A minnows Manipur in a Vijay Hazare Trophy…
This website uses cookies.
